Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
118
-
Total 13F shares, excl. options
-
6.97M
-
Shares change
-
+514K
-
Total reported value, excl. options
-
$275M
-
Value change
-
+$16.6M
-
Put/Call ratio
-
0.78
-
Number of buys
-
67
-
Number of sells
-
-56
-
Price
-
$39.51
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q3 2015
149 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q3 2015.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 118 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.97M shares
of 22.3M outstanding shares and own 31.27% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (1.06M shares), BlackRock Fund Advisors (644K shares), STATE STREET CORP (635K shares), VANGUARD GROUP INC (341K shares), Healthcare Value Capital, LLC (315K shares), SENZAR ASSET MANAGEMENT, LLC (270K shares), GLENMEDE TRUST CO NA (239K shares), WELLS FARGO & COMPANY/MN (236K shares), Allianz Asset Management AG (216K shares), and BlackRock Institutional Trust Company, N.A. (187K shares).
This table shows the top 118 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.